6
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Supportive Care - Essential for Modern Oncology

      Submit here before December 31, 2024

      About Oncology Research and Treatment: 2.0 Impact Factor I 3.2 CiteScore I 0.521 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Effect of Elevated Temperature on Cytotoxic Effector Cells

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several studies have shown a direct correlation between temperature and immune response. The effect of elevated temperature on cytotoxic effector functions is not well known. In the present study we have investigated the effect of elevated temperatures (38.5 and 40 °C) on cytotoxicity of lymphokine-activated killer cells (LAK), monocyte cytotoxicity, cytotoxic T lymphocytes (CTL) and tumor necrosis factor (TNF)-mediated cytotoxicity, and compared them with results at 37°C. LAK cell cytotoxicity was inhibited significantly at 40°C (p < 0.01) and there was no marked difference at 38.5°C (p = 0.17) as compared to 37 °C when natural killer (NK)-sensitive K562 cells were used as target. When NK-resistant Raji cells were used as a target, cytotoxicity was inhibited at 40°C (p = 0.33). Monocyte cytotoxicity was enhanced at 40°C (p= 0.19) as well as at 38.5°C (p = 0.38) as compared to 37°C but differences were not statistically significant. Lipopolysaccharide (LPS) enhanced monocyte cytotoxicity. LPS-stimulated enhancement was further enhanced significantly at 40°C (p < 0.05) and 38.5°C (p < 0.05). Cytotoxicity of CTL was significantly inhibited at 38.5 compared to 37°C (p < 0.0002). TNF-mediated cytotoxicity was significantly enhanced at 40°C (p < 0.0004) and 38.5°C(p < 0.001).

          Related collections

          Author and article information

          Journal
          PAT
          Pathobiology
          10.1159/issn.1015-2008
          Pathobiology
          S. Karger AG
          1015-2008
          1423-0291
          1996
          1996
          08 October 2008
          : 64
          : 3
          : 150-155
          Affiliations
          Departments of aImmunology and bDepartment of Biostatistics, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India
          Article
          164029 Pathobiology 1996;64:150–155
          10.1159/000164029
          8910924
          e04de32e-7bf9-4b2b-8201-39a3c45f81bb
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 15 May 1996
          : 11 June 1996
          Page count
          Pages: 6
          Categories
          Original Paper

          Oncology & Radiotherapy,Pathology,Surgery,Obstetrics & Gynecology,Pharmacology & Pharmaceutical medicine,Hematology
          Lymphokine-activated killer cells,Temperature, elevated,Cytotoxic T lymphocytes,Monocyte cytotoxicity,Tumor necrosis factor

          Comments

          Comment on this article